カリフォルニア州におけるユーイング肉腫の臨床試験
カリフォルニア州内の拠点で、ユーイング肉腫に関する12件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
- Cedars Sinai Medical Center, Los Angeles
- University of California Los Angeles, Los Angeles
被験者募集中第1相
2歳以上 · 全性別 · 2026/09/25更新 · NCT07297979Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Children's Hospital Los Angeles ( Site 1006), Los Angeles
被験者募集中第1/2相
6 Months – 25 Years · 全性別 · 2026/09/17更新 · NCT06395103Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Precision NextGen Oncology and Research, Beverly Hills
- City of Hope, Duarte
- Valkyrie Clinical Trials, Los Angeles
- 他3件
被験者募集中第1相
12歳〜85歳 · 全性別 · 2026/09/08更新 · NCT03715933Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
- University of California San Francisco, San Francisco
被験者募集中第1相
5歳〜40歳 · 全性別 · 2026/09/03更新 · NCT06156410Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- UCSF Benioff Children's Hospital Oakland, Oakland
- Rady Children's Hospital, San Diego
被験者募集中第1/2相
30歳以下 · 全性別 · 2026/09/03更新 · NCT06541262Lurbinectedin in FET-Fused Tumors
- Cedars-Sinai Medical Center, Los Angeles
被験者募集中第1/2相
10歳以上 · 全性別 · 2026/09/02更新 · NCT05918640Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital of Orange County, Orange
- UCSF Medical Center-Mission Bay, San Francisco
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/07/31更新 · NCT07628634A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- The City of Hope National Medical Center, Duarte
- Hoag Memorial Hospital, Newport Beach
被験者募集中第1相
16歳以上 · 全性別 · 2026/06/02更新 · NCT07197554Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/05/19更新 · NCT04901702A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- Kaiser Permanente Oakland Medical Center, Oakland
被験者募集中
13歳以上 · 全性別 · 2026/02/06更新 · NCT06387485Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Children's Hospital of Los Angeles, Los Angeles
- Lucile Packard Children's Hospital, Palo Alto
被験者募集中第1/2相
2歳〜30歳 · 全性別 · 2026/02/03更新 · NCT05734066ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。